Tocilizumab and COVID-19: a meta-analysis of 2120 patients with severe disease and implications for clinical trial methodologies

Piero Schirò Zouina Sarfraz Muzna Sarfraz Hinna Aftab Zainab Pervaiz

Published in: Turkish journal of medical sciences (2021)

This review meta-analyzed the therapeutic benefits of tocilizumab in COVID-19 patients with severe disease for mortality, mechanical ventilation, and the characteristics of COVID-19 registered trials.

Keyphrases

coronavirus disease
sars cov
mechanical ventilation
clinical trial
rheumatoid arthritis
acute respiratory distress syndrome
early onset
rheumatoid arthritis patients
type diabetes
systemic lupus erythematosus
drug induced